Learn More
Invitrogen™ Renilla luciferase Recombinant Rabbit Monoclonal Antibody (SR07-830)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA532013
Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.

Specifications
Renilla luciferase | |
Recombinant Monoclonal | |
1 mg/mL | |
TBS with 0.05% BSA, 40% Glycerol and 0.05% sodium azide; pH 7.4 | |
Rabbit | |
Protein A | |
RUO | |
Renilla | |
Antibody | |
IgG |
Western Blot | |
SR07-830 | |
Unconjugated | |
Renilla-luciferin 2-monooxygenase | |
Recombinant protein within Sea pansy Renilla Luciferase aa 1-96. | |
100 μL | |
Primary | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.